# AAA Pharmaceutical, Inc., Lumberton, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/aaa-pharmaceutical-inc/a4bd33c0-4805-416c-93f2-55e4116cc481

> Inspection records and compliance data for AAA Pharmaceutical, Inc. in Lumberton, New Jersey. 4 FDA inspections on record, 2 Form 483s, last inspected March 28, 2025.

---

## Details

- Name: AAA Pharmaceutical, Inc.
- FEI Number: 3010027650
- Address Line 1: 681 Main St
- City: Lumberton
- State: New Jersey
- Zip Code: 08048
- Country Name: United States
- Address: 681 Main St, Lumberton, New Jersey 08048, United States
- Country: United States

## Related Documents

- [483 - AAA Pharmaceutical, Inc. - 2025-03-28](https://www.keypedia.com/records/483/aaa-pharmaceutical-inc/26bf10f7-11e8-4c0a-bc7f-87be30347209) — source: FDA, date: March 28, 2025
- [FDA Inspection 1253810 - AAA Pharmaceutical, Inc. - 2025-03-28](https://www.keypedia.com/records/fda_inspections/aaa-pharmaceutical-inc/e05f599f-696c-4af5-b70f-08f1beaea16d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 28, 2025
- [483 - AAA Pharmaceutical, Inc. - 2019-04-03](https://www.keypedia.com/records/483/aaa-pharmaceutical-inc/0d44d71b-c849-4775-a502-5679f14945ec) — source: FDA, date: April 3, 2019
- [EIR - AAA Pharmaceutical, Inc. - 2019-04-03](https://www.keypedia.com/records/eir/aaa-pharmaceutical-inc/95beacdd-197a-4ec8-b3a0-1c5f9e57d249) — source: FDA, date: April 3, 2019
- [FDA Inspection 1084922 - AAA Pharmaceutical, Inc. - 2019-04-03](https://www.keypedia.com/records/fda_inspections/aaa-pharmaceutical-inc/e143c598-9a0f-4bd0-850a-c2f61c39964c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 3, 2019
- [FDA Inspection 868581 - AAA Pharmaceutical, Inc. - 2014-03-14](https://www.keypedia.com/records/fda_inspections/aaa-pharmaceutical-inc/7427cdcc-0c17-4b6a-aaac-e720cb752f10) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 14, 2014
- FDA Inspection 817981 - AAA Pharmaceutical, Inc. - 2013-02-13 — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2013

## Related Companies

- [Evonik Corporation](https://www.keypedia.com/companies/evonik-corporation/f88f3afa-3508-4fc2-8d70-8558ece37d59)
- [Eugia SEZ Private Limited](https://www.keypedia.com/companies/eugia-sez-private-limited/c458dd25-5620-40af-93fe-f25936ff47e8)
- [Pharmathen International S.A.](https://www.keypedia.com/companies/pharmathen-international-sa/4486b3e5-4ce8-40ff-80da-e4364db37198)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/6c959344-9e81-4c3c-9e6d-580e25151c7d)
- [Intas Pharmaceuticals Limited](https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8)
- [I 3 PHARMACEUTICALS, LLC](https://www.keypedia.com/companies/i-3-pharmaceuticals-llc/020702e4-1539-47b8-87d9-725035cecbfe)
- [Dr. Reddy's Laboratories Ltd.](https://www.keypedia.com/companies/dr-reddys-laboratories-ltd/769ee88d-49d7-4a19-b97a-63ec71cb7114)
- [Biocon Biologics Limited](https://www.keypedia.com/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d)
- [Eugia Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/9733456f-3189-4fe6-a4f9-327f0ce92559)
- [Mankind Pharma Limited](https://www.keypedia.com/companies/mankind-pharma-limited/448ddf49-4ff4-4a2b-8444-e8cc23677777)

## Related Officers

- [investigator](https://www.keypedia.com/people/michael-l-casner/a0f35f37-4795-4edf-a9f6-a447d64c0fd4)
- [company_representative](https://www.keypedia.com/people/ashwin-patel/12e54e46-0ab4-43b3-b61c-218c7cdfef00)
- [recipient](https://www.keypedia.com/people/tejash-sheth/1f3aa814-bfa6-4984-b48c-f8e33a510743)
- [Tanya R. Syffrard](https://www.keypedia.com/people/tanya-r-syffrard/a78a42b3-6cef-46d9-9698-ec6082956477)
